N-(tert-butoxycarbonyl)-D-phenylglycine N-succinimido ester | 39249-27-9

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: N-(tert-butoxycarbonyl)-D-phenylglycine N-succinimido ester
• 英文别名: Boc-NCCH(Ph)COOSu；Boc-D-Phg-OSu；(2,5-dioxopyrrolidin-1-yl) (2R)-2-[(2-methylpropan-2-yl)oxycarbonylamino]-2-phenylacetate
• CAS: 39249-27-9
• 化学式: C₁₇H₂₀N₂O₆
• 分子量: 348.356
• InChiKey: JPEHHKZULQJYEW-CQSZACIVSA-N

物化性质

• 熔点：
  170-172 °C(Solv: ethyl acetate (141-78-6); hexane (110-54-3))
• 密度：
  1.30±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.7
• 重原子数：
  25
• 可旋转键数：
  7
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.41
• 拓扑面积：
  102
• 氢给体数：
  1
• 氢受体数：
  6

反应信息

• 作为反应物：
  描述：

  N-(tert-butoxycarbonyl)-D-phenylglycine N-succinimido ester 在 palladium on activated charcoal 氢气 、 potassium hydrogencarbonate 、 三氟乙酸 作用下， 以 二氯甲烷 、 水 、 乙酸乙酯 为溶剂， 反应 3.5h， 生成 <<4(S)-methyl-3(S)-<(N⁵-acetyl-N⁵-hydroxy-L-ornithyl-N⁵-acetyl-N⁵-hydroxy-L-ornithyl-N⁵-acetyl-N⁵-hydroxy-L-ornithyl-D-phenylglycyl)amino>-2-oxo-1-azetidinyl>oxy>acetic acid
  参考文献：
  名称：

  Synthesis and siderophore and antibacterial activity of N5-acetyl-N5-hydroxyl-L-ornithine derived siderophore-.beta.-lactam conjugates: iron transport mediated drug delivery

  摘要：

  N5-Acetyl-N5-hydroxy-L-ornithyl-N5-acetyl-N5-hydroxy-L-ornithyl-N5-acetyl-N5-hydroxy-L-ornithine, the functionally instrumental component of the albomycins and ferrichromes, has been incorporated as a ''carrier'' substructure into both carbacephalosporin and oxamazin type beta-lactam antibiotics. The previously synthesized protected version of this tripeptide (14) was coupled with various beta-lactam analogues 17, 19, 24, and 25 to give protected conjugates 21, 22, 26, and 27. Final deprotection by hydrogenolysis provided the deprotected siderophore-beta-lactam antibiotic conjugates 1-4. The growth-promoting ability of each has been evaluated using either the siderophore-deficient mutant Shigella flexneri SA 100 or S. flexneri SA240 (SA 100 iucD:Tn5). Measurement of the growth-promoting activity using two isogenic Escherichia coli strains differing only in the presence or absence of fhuA (hydroxamate ferrichrome receptor) suggests uptake by the hydroxamate iron-transport system. The antibacterial activity of these conjugates has been investigated, and the potential for use of the ferrichrome iron-transport system as a means of drug delivery is discussed.

  DOI：

  10.1021/jm00107a014
• 作为产物：
  描述：

  左旋苯甘氨酸 在 potassium hydrogencarbonate 、 N,N'-二环己基碳二亚胺 作用下， 以 四氢呋喃 、 水 为溶剂， 反应 61.0h， 生成 N-(tert-butoxycarbonyl)-D-phenylglycine N-succinimido ester
  参考文献：
  名称：

  Synthesis and siderophore and antibacterial activity of N5-acetyl-N5-hydroxyl-L-ornithine derived siderophore-.beta.-lactam conjugates: iron transport mediated drug delivery

  摘要：

  N5-Acetyl-N5-hydroxy-L-ornithyl-N5-acetyl-N5-hydroxy-L-ornithyl-N5-acetyl-N5-hydroxy-L-ornithine, the functionally instrumental component of the albomycins and ferrichromes, has been incorporated as a ''carrier'' substructure into both carbacephalosporin and oxamazin type beta-lactam antibiotics. The previously synthesized protected version of this tripeptide (14) was coupled with various beta-lactam analogues 17, 19, 24, and 25 to give protected conjugates 21, 22, 26, and 27. Final deprotection by hydrogenolysis provided the deprotected siderophore-beta-lactam antibiotic conjugates 1-4. The growth-promoting ability of each has been evaluated using either the siderophore-deficient mutant Shigella flexneri SA 100 or S. flexneri SA240 (SA 100 iucD:Tn5). Measurement of the growth-promoting activity using two isogenic Escherichia coli strains differing only in the presence or absence of fhuA (hydroxamate ferrichrome receptor) suggests uptake by the hydroxamate iron-transport system. The antibacterial activity of these conjugates has been investigated, and the potential for use of the ferrichrome iron-transport system as a means of drug delivery is discussed.

  DOI：

  10.1021/jm00107a014

文献信息

• Positionally Isomeric Organic Gelators: Structure-Gelation Study, Racemic versus Enantiomeric Gelators, and Solvation Effects
  作者：Vesna Čaplar、Leo Frkanec、Nataša Šijaković Vujičić、Mladen Žinić

  DOI：10.1002/chem.200902342

  日期：2010.3.8

  (carboxylic acid versus sodium carboxylate), and stereochemistry (racemate versus optically pure form) allowed the identification of gelators with tremendously improved versatility (Gver) and effectiveness (Geff). Dramatic differences in Geff values of up to 70 times could be observed between pure racemate/enantiomer pairs of some gelators, which were manifested even in the gelation of very similar

  设计了由脂肪酸，氨基酸（苯甘氨酸）和ω-氨基脂肪族酸单元组成的低分子量胶凝剂分子。通过分别改变描述符m和n所定义的脂族和ω-氨基脂族酸链中亚甲基单元的数目，获得了一系列位置异构体胶凝剂，它们在胶凝剂分子中的肽氢键合单元的位置不同。位置异构体的胶凝特性已针对一组定义的二十种不同结构和极性的溶剂进行了测定，并根据胶凝剂的多功能性（G ver）和有效性（G eff）进行了分析。）。凝胶试验的结果表明，通过改变m和n，端基极性（羧酸对羧酸钠）和立体化学（外消旋体对光学纯形式）的简单合成优化，“铅凝胶剂分子”就可以鉴定出大大提高了通用性（G ver）和有效性（G eff）的胶凝剂。在某些胶凝剂的纯外消旋体/对映异构体对之间，可以观察到高达70倍的G eff值显着差异，甚至在非常相似的溶剂（如二甲苯异构体）的胶凝中也能表现出这种差异。光谱的综合结果（11 H NMR，FTIR），电子显微镜（TEM）和
• Evaluation of chelating agents as anti-angiogenic therapy through copper chelation
  作者：Kevin Camphausen、Mary Sproull、Steve Tantama、Vincent Venditto、Sandeep Sankineni、Tamalee Scott、Martin W. Brechbiel

  DOI：10.1016/j.bmc.2004.07.034

  日期：2004.10

  The evaluation of several sets of polyamine donor chelating agents including a selection of novel hexadentate 1,3,5-cis,cis-triaminocyclohexane (tach) based derivatives were performed in an in vitro endothelial cell proliferation assay to assess their cytotoxicity and selectivity as novel anti-angiogenic agents. The selective nature of the anti-angiogenic agents for human umbilical vein endothelial cells (HUVEC) was compared to a normal fibroblast cell line and a human Glioma cell line to evaluate these compounds. Linear tri- and tetra-polyamines were superior to both macrocyclic and the tach based polyamine chelating agents in terms of selectivity of its inhibitory activity toward the proliferation of HUVEC cells compared to the fibroblast and human Glioma cells. The linear polyamine, triethylenetetramine (22), previously reported to possess anti-angiogenic properties failed to demonstrate any selectivity for inhibiting the proliferation of HUVEC cells compared to the fibroblast and human Glioma cells. (C) Published by Elsevier Ltd.
• NAKAGUCHI, OSAMU;OKU, TERUO;HASHIMOTO, MASASHI;KAMIYA, TAKASHI, CHEM. AND PHARM. BULL., 35,(1987) N 10, 3979-3984
  作者：NAKAGUCHI, OSAMU、OKU, TERUO、HASHIMOTO, MASASHI、KAMIYA, TAKASHI

  DOI：——

  日期：——
• KIRST, H. A.;TOTH, J. E.;WIND, J. A.;DEBONO, M.;WILLARD, K. E.;MOLLOY, R.+, J. ANTIBIOTICS, 40,(1987) N 6, 823-842
  作者：KIRST, H. A.、TOTH, J. E.、WIND, J. A.、DEBONO, M.、WILLARD, K. E.、MOLLOY, R.+

  DOI：——

  日期：——
• Synthesis and siderophore and antibacterial activity of N5-acetyl-N5-hydroxyl-L-ornithine derived siderophore-.beta.-lactam conjugates: iron transport mediated drug delivery
  作者：E. Kurt Dolence、Albert A. Minnick、Chia En Lin、Marvin J. Miller、Shelley M. Payne

  DOI：10.1021/jm00107a014

  日期：1991.3

  N5-Acetyl-N5-hydroxy-L-ornithyl-N5-acetyl-N5-hydroxy-L-ornithyl-N5-acetyl-N5-hydroxy-L-ornithine, the functionally instrumental component of the albomycins and ferrichromes, has been incorporated as a ''carrier'' substructure into both carbacephalosporin and oxamazin type beta-lactam antibiotics. The previously synthesized protected version of this tripeptide (14) was coupled with various beta-lactam analogues 17, 19, 24, and 25 to give protected conjugates 21, 22, 26, and 27. Final deprotection by hydrogenolysis provided the deprotected siderophore-beta-lactam antibiotic conjugates 1-4. The growth-promoting ability of each has been evaluated using either the siderophore-deficient mutant Shigella flexneri SA 100 or S. flexneri SA240 (SA 100 iucD:Tn5). Measurement of the growth-promoting activity using two isogenic Escherichia coli strains differing only in the presence or absence of fhuA (hydroxamate ferrichrome receptor) suggests uptake by the hydroxamate iron-transport system. The antibacterial activity of these conjugates has been investigated, and the potential for use of the ferrichrome iron-transport system as a means of drug delivery is discussed.